Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 6
2006 4
2007 3
2008 8
2009 8
2010 8
2011 8
2012 12
2013 11
2014 7
2015 5
2016 1
2017 3
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19965548

76 results
Results by year
Filters applied: . Clear all
Page 1
Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.
Wetmore JB, Liu S, Krebill R, Menard R, Quarles LD. Wetmore JB, et al. Clin J Am Soc Nephrol. 2010 Jan;5(1):110-6. doi: 10.2215/CJN.03630509. Epub 2009 Nov 5. Clin J Am Soc Nephrol. 2010. PMID: 19965548 Free PMC article. Clinical Trial.
Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Alon US, et al. Clin J Am Soc Nephrol. 2008 May;3(3):658-64. doi: 10.2215/CJN.04981107. Epub 2008 Feb 6. Clin J Am Soc Nephrol. 2008. PMID: 18256372 Free PMC article. Clinical Trial.
Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study.
Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, Chang JH, Song YR, Hwang YH, Kim YS, Ahn C, Lee J, Oh KH; Representing the Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect Of iPTH Level (CUPID) Study Group. Kim HJ, et al. BMC Nephrol. 2013 May 25;14:112. doi: 10.1186/1471-2369-14-112. BMC Nephrol. 2013. PMID: 23705925 Free PMC article. Clinical Trial.
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.
Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M. Koizumi M, et al. Nephrol Dial Transplant. 2012 Feb;27(2):784-90. doi: 10.1093/ndt/gfr384. Epub 2011 Jul 5. Nephrol Dial Transplant. 2012. PMID: 21730210 Clinical Trial.
Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD. Shireman TI, et al. Am J Kidney Dis. 2010 Dec;56(6):1108-16. doi: 10.1053/j.ajkd.2010.07.012. Epub 2010 Oct 15. Am J Kidney Dis. 2010. PMID: 20951487 Clinical Trial.
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, Goodman W, Cooper K. Sprague SM, et al. Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1021-30. doi: 10.2215/CJN.03270314. Epub 2015 Apr 14. Clin J Am Soc Nephrol. 2015. PMID: 25873267 Free PMC article. Clinical Trial.
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Fishbane S, Shapiro WB, Corry DB, Vicks SL, Roppolo M, Rappaport K, Ling X, Goodman WG, Turner S, Charytan C. Fishbane S, et al. Clin J Am Soc Nephrol. 2008 Nov;3(6):1718-25. doi: 10.2215/CJN.01040308. Clin J Am Soc Nephrol. 2008. PMID: 18945995 Free PMC article. Clinical Trial.
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*. Moe SM, et al. Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9. Circulation. 2015. PMID: 26059012 Free article. Clinical Trial.
Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism.
Kuczera P, Adamczak M, Wiecek A. Kuczera P, et al. Clin Endocrinol (Oxf). 2014 Apr;80(4):607-12. doi: 10.1111/cen.12326. Epub 2013 Oct 10. Clin Endocrinol (Oxf). 2014. PMID: 24111496 Clinical Trial.
Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.
Lee YT, Ng HY, Kuo CC, Chen TC, Wu CS, Chiu TT, Lee WC, Lee CT. Lee YT, et al. Nutrients. 2013 Apr 19;5(4):1336-48. doi: 10.3390/nu5041336. Nutrients. 2013. PMID: 23603995 Free PMC article.
76 results
Jump to page
Feedback